Global Hip Implant Market - Dynamics
Growing geriatric population which is prone to osteoarthritis, and hip fractures, is likely to propel the growth of the hip implants market over the forecast period. For instance, the World Health Organization reported that during 2015-16, nearly 18.0% women and 9.6% men aged 60 years and above had symptomatic osteoarthritis. According to the Australian Institute of Health and Welfare, 2015-16, nearly 18,700 new hip fractures were reported in Australians aged 45 years and above.
Moreover, launches and approvals of various new hip implants are also expected to drive the market growth in near future. For instance, in October 2017, DePuy Synthes announced the first polymethylmethacrylate (PMMA) cement along with the TFNA system which is used to provide improved implant fixation of the hip in cases where potential risk of cut out is significant. Furthermore, in 2018, DePuy Synthes acquired Medical Enterprises Distribution LLC including the orthopedics assets of ME1000, a surgical impactor used in total hip replacement surgery.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
View All Our Clients